论文部分内容阅读
目的探讨布地奈德和特布他林联合雾化吸入治疗慢性阻塞性肺病的临床疗效。方法选择我院2012年1月-2013年1月治疗的80例慢性阻塞性肺病患者,随机分成对照组和观察组各40例,对照组进行消炎、平喘治疗,观察组在此基础上,加布地奈德和特布他林联合雾化吸入治疗。结果观察组咳嗽消失时间为(84.2±1.6)d,啰音消失时间为(7.2±1.2)d,住院时间为(16.2±2.1)d;对照组咳嗽消失时间为(16.6±1.7)d,啰音消失时间为(12.3±1.7)d,住院时间为(24.5±2.8)d;观察组明显短于对照组,两组比较有显著性差异(P<0.05),对照组总有效率为70.0%,观察组总有效率为97.5%,观察组明显优于对照组,两组比较有显著性差异(P<0.05)。结论布地奈德和特布他林联合雾化吸入治疗慢性阻塞性肺病疗效显著,值得推广。
Objective To investigate the clinical efficacy of budesonide and terbutaline combined with inhalation for chronic obstructive pulmonary disease. Methods Eighty patients with chronic obstructive pulmonary disease treated in our hospital from January 2012 to January 2013 were randomly divided into control group and observation group of 40 cases each. The control group was treated with anti-inflammatory and antiasthmatic effects. On the basis of this, Gabpronide and Terbutaline in combination with inhalation therapy. Results The disappearance time of cough in observation group was (84.2 ± 1.6) days, the disappearance time of rales was (7.2 ± 1.2) days and (16.2 ± 2.1) days in hospital. The disappearance time of cough in control group was (16.6 ± 1.7) days (12.3 ± 1.7) d and hospitalization time (24.5 ± 2.8) d, the observation group was significantly shorter than the control group, the difference was significant (P <0.05), the total effective rate was 70.0% , The total effective rate was 97.5% in the observation group, the observation group was significantly better than the control group, the two groups were significantly different (P <0.05). Conclusions Budesonide and terbutaline combined with inhalation therapy for chronic obstructive pulmonary disease have obvious curative effect and should be popularized.